July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Talha Badar: Clinical outcome of AYA with Ph+ve ALL
Jun 18, 2024, 22:49

Talha Badar: Clinical outcome of AYA with Ph+ve ALL

Talha Badar shared on X:         .

“Clinical outcome of adolescents and young adults (AYA) with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ve ALL).

Additional cytogenetic abnormalities are similar in both age groups.

Comparable proportions of patients received intensive chemotherapy (IC) plus tyrosine kinase inhibitors (TKI) and allo-HCT in AYA and non-AYA.”

Image

Source: Talha Badar/X

Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.